Effects of PS128 on Parkinsonian Symptoms

Professor Lu Neurological Clinic

Status

Completed

Conditions

Parkinson Disease

Treatments

Dietary Supplement: Lactobacillus plantarum PS128

Study type

Interventional

Funder types

Other

Identifiers

NCT03566589

PS128-01

Details and patient eligibility

About

The purpose of this study is to examine the short term effects (12 Weeks) of Lactobacillus plantarum PS128 (PS128) on Parkinson's disease (PD) symptoms.

Full description

This study is designed to examine the extent to which L. plantarum PS128 can improve symptoms in PD patients. L. plantarum PS128 is a psychobiotic that regulates the level of dopamine in specific brain regions. Patients with PD will receive PS128 treatment for 12 weeks. Symptoms of PD will be clinically evaluated before and after the treatment, and the results will be compared.

Enrollment

30 patients

Sex

All

Ages

40 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Between ages of 40-80 years old
Diagnosed as a patient with Parkinson's disease of modified Hoehn and Yahr Stage between 1 and 2.5 as rated during an "on" period

Exclusion criteria

Patients on antibiotics within the preceding one month
Patients using of other probiotic products (sachet, capsule or tablet) within the preceding two weeks
Have current or history of inflammatory bowel disease
Have history of cancer
Have undergone surgery of liver, bladder, or gastrointestinal tract
Known allergy to probiotics
Patients with comorbid dementia (Mini-Mental State Examination score ≤ 26) or major depression (The Beck Depression Inventory-II score ≥ 29)
Have received deep brain stimulation
Patients receiving artificial enteral or intravenous nutrition